+91 8744044044 / 8750295029
Global Pharma Network


Elotuzumab is used in combination with lenalidomide and dexamethasone for patients with multiple myeloma who have received 1 to 3 prior therapies.

Generic Version of Elotuzumab Medicine

Query Form

Please fill in the details about your
medicine requirement on this form.

Global Pharma Network

60/4, T&T House. Yusuf Sarai.
New Delhi:110016 India.

Phone number

+91 8744044044



(Primary use: Multiple Myeloma)

Elotuzumab (brand name Empliciti), previously known as HuLuc63) is a humanized monoclonal antibody used in relapsed multiple myeloma. In May 2014, it was granted "Breakthrough Therapy" designation by the FDA (for multiple myeloma). On November 30, 2015, FDA approved elotuzumab as a treatment for patients with multiple myeloma who have received one to three prior medications. Elotuzumab was labeled for use with lenalidomide and dexamethasone. Each intravenous injection of elotuzumab should be premedicated with dexamethasone, diphenhydramine, ranitidine and acetaminophen. In May 2016 the EC/EU gave a similar approval.

Elotuzumab Price, Multiple Myeloma Treatment, Generic Elotuzumab sold under the brand name in India
Elotuzumab is used to treat Multiple Myeloma.

Details of Elotuzumab Medication


Global Pharma Network can help you to provide access of Elotuzumab medications sold under the brand name for Multiple Myeloma treatment by connecting Patients, Health Care Centers, Pharmacies and Retail Outlets with approved supplier, exporter and distributor of Generic drugs, innovator brands and biosimilar medicines from India. Call Mr. Tarun at +91 8744044044 for more details.

For Urgent Requirement "Elotuzumab" Medication

Call at +91 9891296838 / 9811747774 for Elotuzumab availability, Elotuzumab Price and Elotuzumab sold under the brand name. How to procure FDA approved Elotuzumab Drugs for treatment of Multiple Myeloma in India and overseas?

Global Pharma

A Certified Pharmaceutical Wholesaler, Supplier, Exporters from India of FDA approved Elotuzumab a targeted therapy drug sold under the brand name for treatment of Multiple Myeloma in India and overseas. We will help you in importing and exporting this medicine only upon the valid prescription of a licensed medical practitioner and other documents as required by the laws of the jurisdiction in which you are present. USA, UK, Russia, China, India, Nepal, Bhutan, Myanmar / Burma, Laos, Thailand, Cambodia, Hong Kong, Macau, Malaysia, Indonesia, Middle East, Japan, Philippines.


The information on the website is obtained through many different sources and the accuracy should be confirmed prior to use. The content of this website is not intended to be instructional for medical diagnosis or treatment. Always consult with your physician or qualified health care provider on medical issues.